Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
MRTX1719
i
Other names:
MRTX1719
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(7)
News
Trials
Company:
BMS
Drug class:
PRMT5 inhibitor
Related drugs:
‹
AMG 193 (5)
PRT811 (3)
TNG908 (3)
EPZ015666 (2)
PRT543 (2)
MRTX9768 (1)
TNG462 (1)
GSK3326595 (1)
AGX323 (0)
AT101 (0)
GSK591 (0)
LLY-283 (0)
PF-06939999 (0)
SIM0272 (0)
SKL27969 (0)
T1-44 (0)
UCT-000445 (0)
JNJ-64619178 (0)
AMG 193 (5)
PRT811 (3)
TNG908 (3)
EPZ015666 (2)
PRT543 (2)
MRTX9768 (1)
TNG462 (1)
GSK3326595 (1)
AGX323 (0)
AT101 (0)
GSK591 (0)
LLY-283 (0)
PF-06939999 (0)
SIM0272 (0)
SKL27969 (0)
T1-44 (0)
UCT-000445 (0)
JNJ-64619178 (0)
›
Associations
(7)
News
Trials
Search handles
Search handles
Filter by
Latest
2years
First in human #clinicaltrial of @Mirati PRMT5 inhibitor MRTX1719 in MTAP deleted cancers (including #PancreaticCancer) https://t.co/dBbO8Dp5mZ (@Aiims1742)
2 years ago
Clinical
|
MTAP (Methylthioadenosine Phosphorylase) • PRMT5 (Protein Arginine Methyltransferase 5)
|
MTAP deletion
|
MRTX1719
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login